Catalyst Wire Dossier Catalyst Wire Dossier

Tirzepatide (Zepbound)

tirzepatide · Eli Lilly and Company
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tirzepatide (Zepbound), covering 2025-12-15 to 2025-12-15. Get the full timeline:

Most recent: Clinical Trial Update: Study of Tirzepatide for Recovery and Alcohol Use Management [Phase 2]

See pricing